| Hazard Information | Back Directory | [Description]
Tiragolumab is a monoclonal antibody that targets the inhibitory receptor T-cell immunoglobulin and ITIM domain (TIGIT), which is expressed on lymphocytes and suppresses the immune response to cancer. | [Uses]
Tiragolumab is an investigational novel immune checkpoint inhibitor with an intact Fc region and is thought to work as an immune amplifier with other cancer immunotherapies, based on preclinical research. |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18162686757 |
| Website: |
www.biolabreagent.com/ |
|